全文获取类型
收费全文 | 10923篇 |
免费 | 1273篇 |
国内免费 | 179篇 |
专业分类
耳鼻咽喉 | 116篇 |
儿科学 | 184篇 |
妇产科学 | 109篇 |
基础医学 | 411篇 |
口腔科学 | 164篇 |
临床医学 | 2077篇 |
内科学 | 1778篇 |
皮肤病学 | 78篇 |
神经病学 | 758篇 |
特种医学 | 178篇 |
外国民族医学 | 1篇 |
外科学 | 1022篇 |
综合类 | 733篇 |
预防医学 | 2628篇 |
眼科学 | 106篇 |
药学 | 1430篇 |
12篇 | |
中国医学 | 150篇 |
肿瘤学 | 440篇 |
出版年
2024年 | 9篇 |
2023年 | 232篇 |
2022年 | 237篇 |
2021年 | 475篇 |
2020年 | 534篇 |
2019年 | 673篇 |
2018年 | 608篇 |
2017年 | 579篇 |
2016年 | 454篇 |
2015年 | 428篇 |
2014年 | 723篇 |
2013年 | 1130篇 |
2012年 | 606篇 |
2011年 | 708篇 |
2010年 | 541篇 |
2009年 | 496篇 |
2008年 | 496篇 |
2007年 | 515篇 |
2006年 | 437篇 |
2005年 | 380篇 |
2004年 | 344篇 |
2003年 | 305篇 |
2002年 | 270篇 |
2001年 | 222篇 |
2000年 | 154篇 |
1999年 | 134篇 |
1998年 | 102篇 |
1997年 | 79篇 |
1996年 | 84篇 |
1995年 | 60篇 |
1994年 | 49篇 |
1993年 | 49篇 |
1992年 | 34篇 |
1991年 | 34篇 |
1990年 | 24篇 |
1989年 | 20篇 |
1988年 | 21篇 |
1987年 | 15篇 |
1986年 | 9篇 |
1985年 | 8篇 |
1984年 | 25篇 |
1983年 | 8篇 |
1982年 | 15篇 |
1981年 | 10篇 |
1980年 | 9篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
71.
脑卒中后抑郁及其对神经功能康复的影响 总被引:23,自引:0,他引:23
目的:观察脑卒中后抑郁(Post-Stroke Depression,PSD)的发生率和相关因素;探讨选择性5-HT抑制剂对脑卒中后抑郁神经功能康复的影响.方法:选取急性脑脑卒中患者132例(脑梗死78例,脑出血54例),分别在病程2周、1,3,6,12月时给每一位入组患者行PSD诊断、神经功能缺损评分、日常生活能力评分(Activity of Daily Living Scale,ADL)、汉密尔顿抑郁量表(Hamilton Depression Scale,HAMD)评分;同时完成Zung's抑郁自评量表(Self-Rating Depression Scale,SDS)和焦虑自评量表(Self-Rating Anxiety Scale,SAS).结果:①脑卒中患者中约44.70%出现抑郁症状;②脑卒中类型和性别与PSD发生率无相关性(P>0.05);③PSD的发生率和严重程度与神经功能缺损和日常生活能力下降程度有关.④PSD与病变部位、病灶大小、病灶单侧性均无明显相关(P>0.05);⑤氟西汀抗抑郁治疗能明显改善病程3、6个月时的神经功能缺损,病程12月时不仅抑郁症状减轻,日常生活能力改善,神经功能缺损减轻尤为显著.结论:脑卒中后抑郁是急性脑血管病患者常见的长期并发症,并可影响患者功能康复的速度和程度.抗抑郁剂治疗能在抑郁症状明显改善的同时,促进患者日常生活能力和神经功能的恢复. 相似文献
72.
Oxygen consumption at steady state (V˙O
2, l · min−1) and mechanical power (W˙, W) were measured in five subjects riding a human-powered vehicle (HPV, the Karbyk, a four-wheeled recumbent cycle) on a
flat concrete road at constant sub-maximal speeds. The external mechanical work spent per unit of distance (W, J · m−1), as calculated from the ratio of W˙ to the speed (v, m · s−1), was found to increase with the square of v: W˙=8.12+(0.262 ·v
2) (r=0.986, n=31), where the first term represents the mechanical energy wasted, over a unit of distance, against frictional forces (rolling
resistance, Rr), and the second term (k · v
2) is the work performed, per unit distance, to overcome the air drag. The rolling coefficient (Cr, obtained dividing Rr by m · g, where m is the overall mass and g is the acceleration of gravity) amounted to [mean (SD)] 0.0084 (0.0008), that is about 60% higher than that of a racing bicycle.
The drag coefficient was calculated from the measured values of k, air density (ρ) and frontal area (A) [Cx=k · (0.5 · A · ρ)−1], and amounted to 1.067 (0.029), that is about 20% higher than that of a racing bicycle. The energy cost of riding the HPV
(Ck, J · m−1) was measured from the ratio of metabolic power above rest (net V˙O
2, expressed in J · s−1) to the speed (v, m · s−1); the value of this parameter increased with the square of v, as described by: Ck=61.45 + (0.675 · v
2) (r=0.711, n=23). The net mechanical efficiency (η) was calculated from the ratio of W to Ck: over the investigated speed range this turned out to be 0.22 (0.021). Best performance times (BPTs) of a “typical”élite
athlete riding the Karbyk were calculated over the distances of 1, 5 and 10 km: these were about 8% longer than the BPTs calculated,
on the same subjects, when riding a conventional racing bicycle.
Accepted: 7 August 2000 相似文献
73.
目的优化费用成本转换法,进一步完善成本单元划分原则,提高费用成本转换法的核算准确性,推广方法学的应用价值。方法在已有研究的基础上,进一步细分成本单元,采用费用成本转换法测算病种成本,分析病种盈亏情况。结果甲状腺恶性肿瘤治疗成本为37444.48元,平均支付价格为22474.90元,亏损14945.50元,亏损率为39.94%。结论优化后的费用成本转换法更加契合当前医改政策,核算精度更高,有效提升部分专科医院的核算精度。费用成本转换法能够为政府的病种定价与医院运营管理提供科学的方法学支撑。 相似文献
74.
《Value in health》2022,25(10):1705-1716
ObjectivesSuprachoroidal injection of triamcinolone acetonide is the first Food and Drug Administration–approved treatment for macular edema associated with uveitis. A cost-effectiveness analysis was performed comparing this treatment with best supportive care (BSC) for the management of this indication from US Medicare and commercial payer perspectives.MethodsA patient-level simulation was developed per the patient characteristics and changes in best-corrected visual acuity letter scores observed in a phase III study of triamcinolone acetonide (PEACHTREE). The wholesale acquisition cost of triamcinolone acetonide was $1650/injection; suprachoroidal injection cost was assumed at $200/injection. Healthcare costs were informed by a US claims–based analysis. Mortality risk associated with severe vision loss and blindness was modeled by applying a hazard ratio to all-cause mortality rates of the US general population. Health-related quality of life weights, obtained from a regression model fitted to the Visual Function Questionnaire-25 data from PEACHTREE, were applied based on the best-corrected visual acuity scores of both eyes. Costs (2020 US dollar) and benefits were discounted at 3% annually. Incremental cost-effectiveness ratios were estimated over a 10-year horizon.ResultsIn the base-case, the incremental cost-effectiveness ratio comparing triamcinolone acetonide with BSC was $28 479 per quality-adjusted life-year gained. The wholesale acquisition cost for triamcinolone acetonide for suprachoroidal use was ~68%, ~56%, and ~27% below the willingness-to-pay thresholds of $150 000, $100 000, and $50 000 per quality-adjusted life-year gained, respectively. Results were robust in sensitivity and scenario analyses.ConclusionsTriamcinolone acetonide for suprachoroidal use is cost-effective compared with BSC for patients with macular edema associated with uveitis. 相似文献
75.
Many dietary guidelines emphasise “mostly” whole grain food choices as part of an overall healthy eating pattern based on evidence for enhancing nutritional status and reducing chronic disease. Still, countries including Australia fall short of their consumption targets. Furthermore, healthcare cost savings associated with increasing the consumption of whole grains in alignment with the Daily Target Intake (DTI) recommendation of 48 g are unknown. The aim of this study was to assess the potential savings in costs of healthcare and lost productivity associated with a reduction in the incidence of Type 2 Diabetes Mellitus (T2DM) and cardiovascular disease (CVD) through meeting the 48 g DTI recommendation for whole grains among the Australian adult population (>20 years). A three-step cost-of-illness analysis was conducted using input parameters from: 1) estimates of proportions of consumers (5%, 15%, 50%, and 100%) who would increase their current intake of whole grains to meet the recommended DTI in Australia; 2) relative reductions in risk of T2DM and CVD associated with specific whole grain consumption, as reported in meta-analysis studies; and 3) data on costs of healthcare and productivity loss based on monetary figures by national healthcare authorities. A very pessimistic (5% of the population) through to universal (100% of the population) adoption of the recommended DTI was shown to potentially yield AUD 37.5 (95% CI 22.3–49.3) to AUD 750.7 (95% CI 445.7–985.2) million, and AUD 35.9 (95% CI 8.3–60.7) to AUD 717.4 (95% CI 165.5–1214.1) million in savings on annual healthcare and lost productivity costs for T2DM and CVD, respectively. Given such economic benefits of the recommended consumption of whole grains, in exchange for refined grains, there is a real opportunity to facilitate relevant socioeconomic cost-savings for Australia and reductions in disease. These results are suggestive of a much greater opportunity to communicate the need for dietary change at all levels, but particularly through food-based dietary guidelines and front-of-pack labelling initiatives. 相似文献
76.
Sarah A. Collier Li Deng Elizabeth A. Adam Katharine M. Benedict Elizabeth M. Beshearse Anna J. Blackstock Beau B. Bruce Gordana Derado Chris Edens Kathleen E. Fullerton Julia W. Gargano Aimee L. Geissler Aron J. Hall Arie H. Havelaar Vincent R. Hill Robert M. Hoekstra Sujan C. Reddy Elaine Scallan Erin K. Stokes Jonathan S. Yoder Michael J. Beach 《Emerging infectious diseases》2021,27(1):140
Provision of safe drinking water in the United States is a great public health achievement. However, new waterborne disease challenges have emerged (e.g., aging infrastructure, chlorine-tolerant and biofilm-related pathogens, increased recreational water use). Comprehensive estimates of the health burden for all water exposure routes (ingestion, contact, inhalation) and sources (drinking, recreational, environmental) are needed. We estimated total illnesses, emergency department (ED) visits, hospitalizations, deaths, and direct healthcare costs for 17 waterborne infectious diseases. About 7.15 million waterborne illnesses occur annually (95% credible interval [CrI] 3.88 million–12.0 million), results in 601,000 ED visits (95% CrI 364,000–866,000), 118,000 hospitalizations (95% CrI 86,800–150,000), and 6,630 deaths (95% CrI 4,520–8,870) and incurring US $3.33 billion (95% CrI 1.37 billion–8.77 billion) in direct healthcare costs. Otitis externa and norovirus infection were the most common illnesses. Most hospitalizations and deaths were caused by biofilm-associated pathogens (nontuberculous mycobacteria, Pseudomonas, Legionella), costing US $2.39 billion annually. 相似文献
77.
《Journal of the American Medical Directors Association》2022,23(10):1721-1728.e19
ObjectivesEstimate mortality, cost, and health care resource utilization for Medicare beneficiaries aged ≥65 years who suffered a primary Clostridioides difficile infection (CDI) episode only or any recurrent CDI, and understand how outcomes covary with death.DesignRetrospective observational claims analysis.Setting and ParticipantsPatients aged ≥65 years who had an inpatient or outpatient CDI diagnosis claim to Medicare and continuous enrollment in Medicare parts A, B, and D during the 12-month pre- and post-index periods.MethodsUsing 100% Medicare Fee-for-Service claims data for 2009–2017, primary (pCDI, n = 345,893) and recurrent (rCDI: n = 151,596) CDI episodes were identified. Demographic and clinical characteristics, mortality, health care resource utilization, and costs (per patient per month) were summarized for 12 months before and up to 12 months after episode start. Regression models were estimated for hospitalization risk, hospital length of stay (LOS), and cost to adjust for comorbidities.ResultsCDI-associated deaths were almost 10 times higher after recurrent CDI (25.4%) than primary CDI (2.7%). Compared with survivors, decedents were older, had higher Charlson Comorbidity Index scores, and were more likely Black. Adjusting for comorbidities, during follow-up, decedents had higher hospitalization rates [pCDI: odds ratio (OR) = 1.83, P < .001; rCDI: OR = 2.58, P < .001], and recurrent CDI decedents had more intensive care unit use (OR = 2.34, P < .001) compared with survivors. Decedents also had a longer length of stay (pCDI: +3.2 days, P < .001; rCDI: +2.6 days, P < .001), and higher total cost (pCDI: +303%, P < .001; rCDI: +297%, P < .001).Conclusions and ImplicationsCDI is an important contributing diagnosis to all-cause mortality, particularly for recurrences. Prior to death, older Medicare beneficiaries who experienced CDI received longer, more intensive, and more costly care compared with survivors. Clinicians should be particularly attentive to prevention, identification, and appropriate treatment of CDI in older adults. Better treatments to reduce primary C difficile infection and recurrences in this vulnerable population can lower both mortality and economic burden. 相似文献
78.
《Journal of the American Medical Directors Association》2022,23(12):1962.e15-1962.e20
ObjectivesMalnutrition and cognitive impairment are associated with poor functional recovery in older adults following hip-fracture surgery. This study examined the combined effects of cognitive impairment and nutritional trajectories on postoperative functional recovery for older adults following hip-fracture surgery.DesignProspective longitudinal correlational study.Setting and ParticipantsThis study recruited 350 older adults (≥60 years of age) who received hip-fracture surgery at a 3000-bed medical center in northern Taiwan from September 2012 to March 2020.MethodsParticipant data were collected over a 2-year period after surgery for nutritional and cognitive status and activities of daily living (ADLs). Participants were grouped by type of nutritional trajectory using group-based trajectory modeling. Generalized estimating equations analyzed associations between trajectory groups/cognitive status at discharge and performance of ADLs.ResultsNutritional trajectories best fit a 3-group trajectory model: malnourished (19%), at-risk of malnutrition (40%), and well-nourished (41%). Nutritional status for the malnourished group declined from 12 months to 24 months following surgery; nutritional status remained stable for at-risk of malnutrition and well-nourished groups. Interactions for cognitive impairment-by-nutritional status were significant: the malnourished + intact cognition subgroup had significantly better ADLs than the malnourished + cognitive impairment subgroup (b = 27.1, 95% confidence interval = 14.0–40.2; P < .001). For at-risk of malnutrition and well-nourished groups, there were no significant differences between cognitive impairment and intact cognition in ADLs. These findings suggest that nutritional status may buffer the negative effect of cognitive impairment on ADLs.Conclusions and ImplicationsBetter nutritional status over time for older adults following hip fracture can protect against adverse influences of cognitive impairment on ADLs during postoperative recovery. Participants with malnutrition and cognitive impairment had the poorest ADLs. These findings suggest interventions tailored to improving nutritional status may improve recovery for older adults following hip-fracture surgery. 相似文献
79.
管怀鎏 《南通大学学报(哲学社会科学版)》2001,17(4):46-51
现代市场经济运行中 ,厂商将其供给量调整到合理水平所需的费用可称为微观调节成本。由于存在微观调节成本这种特殊的经济运行费用 ,因而传统分析中宏观层面上市场就业均衡点的两侧便分别存在着“低位临界点”与“高位临界点” ,这两点界定了一个“市场均衡就业区间” ,社会就业一旦进入该区间 ,市场机制便不可能再对其作出调节。市场均衡就业区间的主要特点在于 ,其均衡是就区间外部而言的 ,在区间内部仍可以存在一定程度的就业失衡 ;市场均衡就业区间内部的就业失衡是一种特殊的就业失衡 ,市场机制对之无能为力 ,一般的宏观经济政策亦无法对其发生作用。市场均衡就业区间的存在对社会就业有着多方面的重要影响 ,它使社会就业对供求总量波动的反应呈现出一定“粘性” ;使市场机制对社会就业的调节空间减小 ;使政府调控社会就业的重点二元化 ;使个体经济在缓解就业失衡压力、扩大社会就业方面占有了特殊重要的地位。 相似文献
80.
Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States
Ajay Premkumar David A. Kolin Kevin X. Farley Jacob M. Wilson Alexander S. McLawhorn Michael B. Cross Peter K. Sculco 《The Journal of arthroplasty》2021,36(5):1484-1489.e3
BackgroundIn addition to the significant morbidity and mortality associated with periprosthetic joint infection (PJI), the cost of treating PJI is substantial. Prior high-quality national estimates of the economic burden of PJI utilize data up to 2009 to project PJI growth in the United States through 2020. Now in the year 2020, it is appropriate to evaluate these past projections and incorporate the latest available data to better understand the current scale and burden of PJI in the United States.MethodsThe Nationwide Inpatient Sample (2002-2017) was used to identify rates and associated inpatient costs for primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) and PJI-related revision TKA and THA. Poisson regression was utilized to model past growth and project future rates and cost of PJI of the hip and knee.ResultsUsing the most recent data, the combined annual hospital costs related to PJI of the hip and knee were estimated to be $1.85 billion by 2030. This includes $753.4 million for THA PJI and $1.1 billion for TKA PJI, in that year. Increases in PJI costs are mainly attributable to increases in volume. Although the growth in incidence of primary THA and TKA has slowed in recent years, the incidence of PJI and the cost per case of PJI remained relatively constant from 2002 to 2017.DiscussionUnderstanding the current and potential future financial burden of PJI for surgeons, patients, and healthcare systems is essential. There is an urgent need for efficacious preventive strategies in reducing rates of PJI after THA and TKA. 相似文献